InvestorsHub Logo
Followers 275
Posts 8619
Boards Moderated 0
Alias Born 10/05/2010

Re: None

Friday, 08/29/2014 8:32:21 AM

Friday, August 29, 2014 8:32:21 AM

Post# of 16
This one looks interesting.

http://www.coquipharma.com/wordpress1/

http://lifescienceinvestingnews.com/3664-coqui-radiopharmaceuticals-molybdenum-99-united-states.html

Description of Business

The Company's business plan is to consummate the reverse acquisition transaction with Coquí which intends to establish a dedicated Medical Isotope Production Facility in the United States to provide a reliable domestic source of certain radioisotopes for use in nuclear medicine. In order to accomplish this, substantial additional capital must be raised. Moreover, there are a number of material contingencies including approval by the Nuclear Regulatory Commission ("NRC"). To date, no application has been filed by Coquí due to insufficient working capital. There is no assurance that the Company will be able to successfully implement this business plan or that the execution of the same will result in the appreciation of our stockholders' investment in the Company's common stock. The Company intends to consummate such merger as soon as Coquí finishes auditing its financial statements required to permit it to comply with applicable Securities and Exchange Commission rules.


WELCOME TO

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.